0 Commentaires
0 Parts
636 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 Commentaires 0 Parts 548 Vue 0 Aperçu
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has incorporated...0 Commentaires 0 Parts 499 Vue 0 Aperçu
-
Cell Cycle Inhibitors Market Advancing Targeted Cancer TreatmentsIn-Depth Study on Executive Summary Cell Cycle Inhibitors Market Size and Share CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. This Cell Cycle Inhibitors Market report is structured with the thorough market analysis carried...0 Commentaires 0 Parts 516 Vue 0 Aperçu
-
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...0 Commentaires 0 Parts 1KB Vue 0 Aperçu